BioNTech (BNTX) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free BNTX Stock Alerts $92.98 +0.78 (+0.85%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 6:22 AM | americanbankingnews.comBioNTech (NASDAQ:BNTX) Now Covered by Analysts at Evercore ISIMay 15 at 5:20 AM | marketbeat.comNatixis Advisors L.P. Makes New $1.66 Million Investment in BioNTech SE (NASDAQ:BNTX)Natixis Advisors L.P. bought a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 15,766 shares of the company's stock, valued at approximately $1,66May 14 at 11:55 PM | marketbeat.comShort Interest in BioNTech SE (NASDAQ:BNTX) Grows By 16.8%BioNTech SE (NASDAQ:BNTX - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,690,000 shares, a growth of 16.8% from the April 15th total of 3,160,000 shares. Currently, 1.6% of the company's shares are sold short. Based on an average trading volume of 594,100 shares, the days-to-cover ratio is currently 6.2 days.May 14 at 5:34 PM | msn.comEvercore ISI Group Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with In-Line RecommendationMay 13, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for BioNTech SE (NASDAQ:BNTX) Increased by HC WainwrightMay 12, 2024 | marketbeat.comTruist Financial Corp Buys Shares of 13,694 BioNTech SE (NASDAQ:BNTX)Truist Financial Corp purchased a new position in BioNTech SE (NASDAQ:BNTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 13,694 shares of the company's stock, valued at approximately $1,445,000. A number of other institutional investMay 12, 2024 | americanbankingnews.comBioNTech (NASDAQ:BNTX) Price Target Increased to $113.00 by Analysts at HC WainwrightMay 11, 2024 | finance.yahoo.comWe Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This YearMay 11, 2024 | americanbankingnews.comBioNTech SE (NASDAQ:BNTX) Expected to Post Q1 2025 Earnings of ($2.31) Per ShareMay 11, 2024 | americanbankingnews.comBioNTech SE (NASDAQ:BNTX) Given Average Rating of "Hold" by BrokeragesMay 10, 2024 | marketbeat.comBioNTech SE (NASDAQ:BNTX) to Post Q1 2025 Earnings of ($2.31) Per Share, HC Wainwright ForecastsBioNTech SE (NASDAQ:BNTX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Wednesday, May 8th. HC Wainwright analyst R. Burns expects that the company will post earnings of ($2.31) per shareMay 9, 2024 | americanbankingnews.comBioNTech (NASDAQ:BNTX) PT Raised to $98.00May 8, 2024 | markets.businessinsider.comDeutsche Numis Reaffirms Their Hold Rating on BioNTech SE (BNTX)May 8, 2024 | finance.yahoo.comBioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 8, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Price Target Raised to $113.00HC Wainwright boosted their target price on BioNTech from $107.00 to $113.00 and gave the stock a "buy" rating in a report on Wednesday.May 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioNTech Amid Strong Financials and Promising Oncology PipelineMay 8, 2024 | americanbankingnews.comBioNTech (NASDAQ:BNTX) Price Target Lowered to $122.00 at BMO Capital MarketsMay 8, 2024 | americanbankingnews.comBioNTech (NASDAQ:BNTX) Price Target Raised to $98.00 at TD CowenMay 7, 2024 | markets.businessinsider.comStrong Financials and Promising Oncology Pipeline Support Buy Rating for BioNTech SEMay 7, 2024 | msn.comBioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market SessionMay 7, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) PT Lowered to $122.00BMO Capital Markets decreased their target price on BioNTech from $123.00 to $122.00 and set an "outperform" rating for the company in a research report on Tuesday.May 7, 2024 | markets.businessinsider.comBuy Rating for BioNTech SE on Strong H2 Revenue Outlook and Promising Oncology PipelineMay 7, 2024 | markets.businessinsider.comBioNTech: Hold Rating Maintained Amidst Lower Q1 Earnings and Steady Revenue OutlookMay 7, 2024 | americanbankingnews.comBioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)May 6, 2024 | msn.comBioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents ToplineMay 6, 2024 | finance.yahoo.comWhat's Going With BioNTech Stock On Monday?May 6, 2024 | fool.comBioNTech Se (BNTX) Q1 2024 Earnings Call TranscriptMay 6, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Down to $92.72BioNTech (NASDAQ:BNTX) Shares Gap Down to $92.72May 6, 2024 | investorplace.comBNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | marketbeat.comBioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)BioNTech SE (NASDAQ:BNTX - Get Free Report) saw some unusual options trading activity on Monday. Investors bought 1,989 call options on the stock. This represents an increase of approximately 31% compared to the typical volume of 1,519 call options.May 6, 2024 | seekingalpha.comBioNTech SE 2024 Q1 - Results - Earnings Call PresentationMay 6, 2024 | investopedia.comBioNTech's Outlook Gives Vaccine Maker a Shot in the ArmMay 6, 2024 | barrons.comBioNTech Revenue Falls Sharply on Reduced Covid Vaccine SalesMay 6, 2024 | finanznachrichten.deBioNTech SE: BioNTech Announces First Quarter 2024 Financial Results and Corporate UpdateMay 6, 2024 | marketwatch.comBioNTech Swings to Net Loss on Lower Covid Vaccine SalesMay 6, 2024 | markets.businessinsider.comBioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-marketMay 6, 2024 | markets.businessinsider.comBioNTech Slips To Loss In Q1May 6, 2024 | reuters.comBioNTech says 90% of 2024 revenues will accrue at end of yearMay 6, 2024 | globenewswire.comBioNTech Announces First Quarter 2024 Financial Results and Corporate UpdateMay 5, 2024 | marketbeat.comKestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)Kestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 8,883 shares of the company's stock, valued at approxiMay 3, 2024 | seekingalpha.comBioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma CompanyMay 3, 2024 | seekingalpha.comBioNTech Earnings Preview: I Will Stay On The SidelinesMay 3, 2024 | marketbeat.comVan ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)Van ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,696 shares of the company's stock after selling 17,318April 26, 2024 | msn.comCOVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent BattleApril 26, 2024 | marketbeat.com103,858 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by abrdn plcabrdn plc purchased a new position in BioNTech SE (NASDAQ:BNTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 103,858 shares of the company's stock, valued at approximately $10,961,000.April 25, 2024 | msn.comWhat's Going On With Pfizer Stock On Thursday?April 25, 2024 | msn.comGSK sues Pfizer, BioNTech over COVID-19 vaccines patentsApril 25, 2024 | reuters.comGlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyApril 23, 2024 | marketbeat.comMackenzie Financial Corp Has $2.30 Million Stake in BioNTech SE (NASDAQ:BNTX)Mackenzie Financial Corp grew its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 326.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 21,874 shares of the company's stock after purchasing an additionalApril 22, 2024 | globenewswire.comBioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BNTX Media Mentions By Week BNTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.960.54▲Average Medical News Sentiment BNTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼209▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: argenx News Today Neurocrine Biosciences News Today Bio-Techne News Today Biogen News Today Qiagen News Today Repligen News Today Vaxcyte News Today Revolution Medicines News Today Exelixis News Today ImmunityBio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
